chr3-158807396-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000415822.8(MFSD1):c.373G>A(p.Val125Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000103 in 1,611,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000415822.8 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFSD1 | NM_022736.4 | c.373G>A | p.Val125Ile | missense_variant, splice_region_variant | 5/16 | ENST00000415822.8 | NP_073573.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD1 | ENST00000415822.8 | c.373G>A | p.Val125Ile | missense_variant, splice_region_variant | 5/16 | 1 | NM_022736.4 | ENSP00000403117 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250878Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135612
GnomAD4 exome AF: 0.000103 AC: 150AN: 1459014Hom.: 0 Cov.: 30 AF XY: 0.000101 AC XY: 73AN XY: 725958
GnomAD4 genome AF: 0.000105 AC: 16AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2023 | The c.520G>A (p.V174I) alteration is located in exon 5 (coding exon 5) of the MFSD1 gene. This alteration results from a G to A substitution at nucleotide position 520, causing the valine (V) at amino acid position 174 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at